Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) (BRIDGE)

This study has been completed.
Sponsor:
Collaborator:
Genzyme, a Sanofi Company
Information provided by (Responsible Party):
Schetelig Johannes, Technische Universität Dresden
ClinicalTrials.gov Identifier:
NCT01295307
First received: February 4, 2011
Last updated: October 6, 2015
Last verified: October 2015